Ganirelix is a synthetic hormone used in fertility treatments that works by preventing premature ovulation. During the manufacturing process of Ganirelix, impurities can be introduced which may affect the quality and safety of the final product. These impurities can include residual solvents, degradation products, and other chemical compounds that may be harmful to the patient. It is important to closely monitor and control impurities during the production of Ganirelix to ensure its efficacy and safety.
